2021-03-31-accounts - The Epsom And St Helier NHS Trust Charitable Fund

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

hown in the table belo	w:
	Role	Dates in post during
		2020/2021
Gillian Norton	Chairman	31/3/20 to 31/3/21
Patricia Baskerville	Non-Executive	31/3/20 to 31/12/20
Elizabeth Bishop	Non-Executive	31/3/20 to 31/3/21
Professor Derek Macallan	Non-Executive Director	31/3/20 to 31/3/21
Phillip Wilbraham	Non-Executive Director	3/0/20 to 31/3/21
Richard Noble	Non-Executive Director	31/3/20 to 31/3/21
Aruna Mehta	Non-Executive Director	31/3/20 to 31/3/21
Martin Kirke	Ass Non Executive Director	31/3/20 to 31/3/21
Chris Elliot	Ass Non Executive Director	31/3/20 to 31/3/21
Daniel Elkeles	Chief Executive	31/3/20 to 31/3/21
Rakesh Patel	Chief Finance Officer	31/3/20 to 31/3/21
DrJames Marsh	Deputy Chief Executive and Joint Medical Director	31/3/20 to 31/3/21
Dr Ruth Charlton	Deputy Chief Executive and Joint Medical Director	31/3/20 to 31/3/21
Sue Jones	Joint Chief Operating Officer	31/3/20 to 31/3/21
Phillips Jones	Joint Chief Operating Officer	31/3/20 to 31/3/21
Arlene Wellman	Chief Nurse	31/3/20 to 31/3/21
Debbie Eyitayo	Director ofPeople	31/3/20 to 31/3/21
Peter Davies	Director ofStrategy	31/3/20 to 31/3/21
Trevor Fitzgerald	Director of Estates Facilities and Capital Projects	31/3/20 to 31/3/21
Thirza Sawtell	Director of Integrated Care	31/3/20 to 31/3/21
Lisa Thomson	Director ofCommunications	1/4/20 to 31/7/20

				2020t2021		2019/2020	2019/2020
			Unrestricted	Restricted	Total	Unrestrlcts	Restricts	Total
						d	d
			Funds	Furtds	Funds	Funds	Funds	Funds
			fr000	6'000	fr000	M000	M000	K'000
Income from:
Donations		Note 3	226	176	402	190	186	370
Other trading activities		Note 3	11	0	11	28	0	28
Legacies		Note 3	354	0	354	143	0	143
Investment Income		Note 5	27	0	27	42	0	42
Total Income			618	176	794	403	188	591
Expenditure on:
Raising funds
Investment management Fundraising Costs	costs	Note 6	(26) (96)	(3) 0	(29) (98)	(0) (73)	0 0	(9) (73)
Expenditure on charilabie
activities
Patients welfare and amenities Staffwelfare and amenities Research Expenditure DonatIons ofequipment and		Note 7 Note 7 Note 7 Note 7	n) (83) n) (162)	0 (150) 0 0	(1) (213) (1) (182)	(13) (66) 0 (675)	0 0 0 0	(13) (88) 0 (675)
sslvlces to the Trust
Volunteers and miscellaneous		Note 7	0	0	0	(0)	0	(9)
expenses
Total Expenditure			(369)	(153)	(522)	(867)	0	(867)
Realised and Unrealised	Gains		526	36	582	(120)	0	(128)
(losses) on Investment	assets
Net Movement In Funds			775	59	034	590	108	402
Reconciliation offunds:
Fund balances brought	forward		2,397	185	2,585
as at 1 April 2020
Fund balances brought	forward					2,967	0	2,987
as at 1 April 2019
Total Funds carried forward		Note	3,172	247	8,419	2,397	108	2,505
		16

			2020I21			2019I2020
		Unrestricted	Restricted	Total	Unrestricted	Restricted	Total
		Funds	Funds	Funds	Funds	Funds	Funds
		ir000	E'000	E'000	E'000	E'000	E'000
Investments	Note 13				2413	0	2413
Total Fixed Assets		2,973	0	2,973	2,413	0	2,413
Receivables	Note 14	15	0	15	21	0	21
Stock		1	0	1	1	0	1
Cash at bank and in hand		463	247	710	202	188	3$0
Total Current Assets		47$	24'r	726	224	188	412
Payables: falling due within	Note 15	(280)	0	(280)	(240)	0	(240)
one year
Net Current Assets I		199			(16)	188	172
(Llab8ltles)
Total net assets		3172	247	3419	2397	188	2585
Funds ofthe charity:
Restricted	Note 16		247	247	0	186	188
Unrestricted Total Charity Funds	Note 16	3,172 3172	250	3,172 2,3$7 3192397		0 188	2,3$7 2 85

Statement ofCash F	low	s	for the	year	ending 31	March 2021
							20/20/21	2019/20
							8'000	8'000
Cash flows from operating activities:
Net cash provided by (used in) operating		activities					293	(496)
Cash flows from investing activities:
Dividends, interest and rents from investments							27	42
Proceeds from sale ofinvestments							0	0
Purchase ofinvestments							0	0
Net cash provided by (used in) investing	activities						27	42
Change in cash and cash equivalents	in the reporting			period			320	454
Cash and cash equivalents at the beginning			ofthe reporting		period		390	844
Cash and cash equivalents at the end	ofthe reporting			period			710	390
Reconciliation ofnet Income/(expenditure)			to net cash flow		from operating	activities
Net income/(expenditure) forthe reporting			period (as	per the	statement of
financial activities)							834	(402)
Adjustments for:
(Gains)/losses on investments							(562)	128
Dividends, interest and rents from investments (Increase)/dscrease in stock							(25) 0	(74) 0
(Increase)/decrease in receivables Increase/(decrease) in payables							6 40	(20) (128)
Net cash provided by (used in) operating		activities					293	496
Analysis ofcash and cash equivalents
Cash at bank and in hand							710	390

Note 3In	com	e from donation	s and legacies	s and legacies
			2020/2021			2019/20
			Unrestricted	Restricted	Total	Total
			Funds	Funds	Funds	Funds
			6'000	6'000	2'000	6'000
Voluntary	Income:
Donations			226	176	402	378
Legacies			354	0	354	143
Trading	Income		11	0	11	28
Total Voluntary		Income:	591	176	767	549

					2020/2021		2019/20
				Grant
				funded	Support	Total	Total
				activity	costs	Expenditure	Expenditure
				8'000	E'000	8'000	8'000
Patients welfare and amenities				1	0	1	13
Staff welfare and amenities				191	22	213	88
Research	Expenditure			1	0	1	0
Donations	ofequipment	and services to the Trust		163	19	182	675
Volunteers	and miscellaneous		expenses	0	0	0	9
				356	41	397	785

econciliation ofmovements in i	nvestments in the y	ear:
		2020/2021	2019/20
		f'000	f'000
Market value brought forward		2,413	2,511
Add: additions to investments at cost Less: disposals at carrying value Add net gain(loss) on revaluation/Other	movements	0 0 560	1,649 (1,611) ~133
Market value as at 31st March		2,973	2,413

ixed asset investments by ty	pe:
		2020/2021	2019/20
		f'000	f'000
Investments-
Fixed Interest		0	0
UK Equities		121	110
Overseas Equities		1,009	757
UK Bonds		182	167
Property/ Alternatives		200	205
Multi Asset fund		1,357	1 323
Total listed investments		2,889	2,262
Cash held as part ofthe investment	porffolio	104	151
		2973	2,413